Retinoid X Receptor Is Necessary to Establish the S-Opsin Gradient In
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Detailed Review Paper on Retinoid Pathway Signalling
1 1 Detailed Review Paper on Retinoid Pathway Signalling 2 December 2020 3 2 4 Foreword 5 1. Project 4.97 to develop a Detailed Review Paper (DRP) on the Retinoid System 6 was added to the Test Guidelines Programme work plan in 2015. The project was 7 originally proposed by Sweden and the European Commission later joined the project as 8 a co-lead. In 2019, the OECD Secretariat was added to coordinate input from expert 9 consultants. The initial objectives of the project were to: 10 draft a review of the biology of retinoid signalling pathway, 11 describe retinoid-mediated effects on various organ systems, 12 identify relevant retinoid in vitro and ex vivo assays that measure mechanistic 13 effects of chemicals for development, and 14 Identify in vivo endpoints that could be added to existing test guidelines to 15 identify chemical effects on retinoid pathway signalling. 16 2. This DRP is intended to expand the recommendations for the retinoid pathway 17 included in the OECD Detailed Review Paper on the State of the Science on Novel In 18 vitro and In vivo Screening and Testing Methods and Endpoints for Evaluating 19 Endocrine Disruptors (DRP No 178). The retinoid signalling pathway was one of seven 20 endocrine pathways considered to be susceptible to environmental endocrine disruption 21 and for which relevant endpoints could be measured in new or existing OECD Test 22 Guidelines for evaluating endocrine disruption. Due to the complexity of retinoid 23 signalling across multiple organ systems, this effort was foreseen as a multi-step process. -
Retinoid X Receptor'' B-Mediated TSLP Expression by Κ NF
Comment on ''Cutting Edge: Inhibition of NF- κB-Mediated TSLP Expression by Retinoid X Receptor'' This information is current as Janine Gericke, Anat Gamlieli, Kathrin Weiss and Ralph of September 23, 2021. Rühl J Immunol 2009; 182:3; ; doi: 10.4049/jimmunol.182.1.3-a http://www.jimmunol.org/content/182/1/3.1 Downloaded from References This article cites 3 articles, 2 of which you can access for free at: http://www.jimmunol.org/content/182/1/3.1.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 23, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Letters to the Editor 2. Allenby, G., M. T. Saunders, M. Saunders, S. Kazmer, J. Speck, M. Rosenberger, A. Comment on “Cutting Edge: Lovey, P. Kastner, J. F. Grippo, P. Chambon, et al. 1993. Retinoic acid receptors and Inhibition of NF-B-Mediated retinoid X receptors: interactions with endogenous retinoic acids. -
Role of Nuclear Receptors in Central Nervous System Development and Associated Diseases
Role of Nuclear Receptors in Central Nervous System Development and Associated Diseases The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Olivares, Ana Maria, Oscar Andrés Moreno-Ramos, and Neena B. Haider. 2015. “Role of Nuclear Receptors in Central Nervous System Development and Associated Diseases.” Journal of Experimental Neuroscience 9 (Suppl 2): 93-121. doi:10.4137/JEN.S25480. http:// dx.doi.org/10.4137/JEN.S25480. Published Version doi:10.4137/JEN.S25480 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:27320246 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Journal name: Journal of Experimental Neuroscience Journal type: Review Year: 2015 Volume: 9(S2) Role of Nuclear Receptors in Central Nervous System Running head verso: Olivares et al Development and Associated Diseases Running head recto: Nuclear receptors development and associated diseases Supplementary Issue: Molecular and Cellular Mechanisms of Neurodegeneration Ana Maria Olivares1, Oscar Andrés Moreno-Ramos2 and Neena B. Haider1 1Department of Ophthalmology, Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA. 2Departamento de Ciencias Biológicas, Facultad de Ciencias, Universidad de los Andes, Bogotá, Colombia. ABSTRACT: The nuclear hormone receptor (NHR) superfamily is composed of a wide range of receptors involved in a myriad of important biological processes, including development, growth, metabolism, and maintenance. -
Pathway Development Via Retinoid X Receptor Vitamin a Enhances In
Vitamin A Enhances in Vitro Th2 Development Via Retinoid X Receptor Pathway This information is current as Charles B. Stephensen, Reuven Rasooly, Xiaowen Jiang, of September 24, 2021. Michael A. Ceddia, Casey T. Weaver, Roshantha A. S. Chandraratna and R. Patterson Bucy J Immunol 2002; 168:4495-4503; ; doi: 10.4049/jimmunol.168.9.4495 http://www.jimmunol.org/content/168/9/4495 Downloaded from References This article cites 40 articles, 24 of which you can access for free at: http://www.jimmunol.org/content/168/9/4495.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 24, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2002 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Vitamin A Enhances in Vitro Th2 Development Via Retinoid X Receptor Pathway1 Charles B. Stephensen,2* Reuven Rasooly,* Xiaowen Jiang,* Michael A. Ceddia,3* Casey T. Weaver,† Roshantha A. S. Chandraratna,‡ and R. Patterson Bucy† Vitamin A deficiency diminishes Th2-mediated Ab responses, and high-level dietary vitamin A or treatment with the vitamin A metabolite retinoic acid (RA) enhances such responses. -
The Role of Signal Transducer and Activator of Transcription 5 in the Inhibitory Effects of GH on Adipocyte Differentiation
139 The role of signal transducer and activator of transcription 5 in the inhibitory effects of GH on adipocyte differentiation H E Richter1, T Albrektsen2 and N Billestrup1,3 1Department of Signal Transduction, Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Denmark 2Department of Transcription Biology, Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Denmark 3Steno Diabetes Centre, Niels Steensensvej 6, DK-2820 Gentofte, Denmark (Requests for offprints should be addressed to N Billestrup, Steno Diabetes Centre, Niels Steensensvej 6, NSK2·023, DK-2820 Gentofte, Denmark; Email:[email protected]) Abstract GH inhibits primary rat preadipocyte differentiation and expression of late genes required for terminal differentiation. Here we show that GH-mediated inhibition of fatty acid-binding protein aP2 gene expression correlates with the activation of the Janus kinase-2/signal transducer and activator of transcription (STAT)-5 signalling pathway. Within minutes of treatment, GH induced the tyrosine phosphorylation, nuclear localization and DNA binding of STAT5. Importantly, there was no evidence that STAT5 acted via an interaction with peroxisome proliferator-activated receptor γ. To further understand the mechanism of STAT5 action, we reconstituted the inhibition of aP2 in a non-adipogenic cell line. Using this system, we showed that the ability of GH to inhibit a 520 bp aP2 reporter was largely dependent upon the presence of either STAT5A or STAT5B. Mutant analysis confirmed that the tyrosine phosphorylation of STAT5 was essential for this signalling. However, STAT5’s C-terminal transactivation domain was fully dispensable for this inhibition. Taken together, these data confirm a key regulatory role of STAT5 in adipose tissue and point to STAT5 as the repressing modulator of GH-mediated inhibition in primary preadipocytes. -
Nuclear Hormone Receptor Antagonism with AP-1 by Inhibition of the JNK Pathway
Downloaded from genesdev.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway Carme Caelles,1 Jose´M. Gonza´lez-Sancho, and Alberto Mun˜oz2 Instituto de Investigaciones Biome´dicas, Consejo Superior de Investigaciones Cientı´ficas, E-28029 Madrid, Spain The activity of c-Jun, the major component of the transcription factor AP-1, is potentiated by amino-terminal phosphorylation on serines 63 and 73 (Ser-63/73). This phosphorylation is mediated by the Jun amino-terminal kinase (JNK) and required to recruit the transcriptional coactivator CREB-binding protein (CBP). AP-1 function is antagonized by activated members of the steroid/thyroid hormone receptor superfamily. Recently, a competition for CBP has been proposed as a mechanism for this antagonism. Here we present evidence that hormone-activated nuclear receptors prevent c-Jun phosphorylation on Ser-63/73 and, consequently, AP-1 activation, by blocking the induction of the JNK signaling cascade. Consistently, nuclear receptors also antagonize other JNK-activated transcription factors such as Elk-1 and ATF-2. Interference with the JNK signaling pathway represents a novel mechanism by which nuclear hormone receptors antagonize AP-1. This mechanism is based on the blockade of the AP-1 activation step, which is a requisite to interact with CBP. In addition to acting directly on gene transcription, regulation of the JNK cascade activity constitutes an alternative mode whereby steroids and retinoids may control cell fate and conduct their pharmacological actions as immunosupressive, anti-inflammatory, and antineoplastic agents. -
Interplay Between P53 and Epigenetic Pathways in Cancer
University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2016 Interplay Between P53 and Epigenetic Pathways in Cancer Jiajun Zhu University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Biology Commons, Cell Biology Commons, and the Molecular Biology Commons Recommended Citation Zhu, Jiajun, "Interplay Between P53 and Epigenetic Pathways in Cancer" (2016). Publicly Accessible Penn Dissertations. 2130. https://repository.upenn.edu/edissertations/2130 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/2130 For more information, please contact [email protected]. Interplay Between P53 and Epigenetic Pathways in Cancer Abstract The human TP53 gene encodes the most potent tumor suppressor protein p53. More than half of all human cancers contain mutations in the TP53 gene, while the majority of the remaining cases involve other mechanisms to inactivate wild-type p53 function. In the first part of my dissertation research, I have explored the mechanism of suppressed wild-type p53 activity in teratocarcinoma. In the teratocarcinoma cell line NTera2, we show that wild-type p53 is mono-methylated at Lysine 370 and Lysine 382. These post-translational modifications contribute ot the compromised tumor suppressive activity of p53 despite a high level of wild-type protein in NTera2 cells. This study provides evidence for an epigenetic mechanism that cancer cells can exploit to inactivate p53 wild-type function. The paradigm provides insight into understanding the modes of p53 regulation, and can likely be applied to other cancer types with wild-type p53 proteins. On the other hand, cancers with TP53 mutations are mostly found to contain missense substitutions of the TP53 gene, resulting in expression of full length, but mutant forms of p53 that confer tumor-promoting “gain-of-function” (GOF) to cancer. -
The Histone Acetylase PCAF Is a Nuclear Receptor Coactivator
Downloaded from genesdev.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press The histone acetylase PCAF is a nuclear receptor coactivator Jorge C.G. Blanco,1,4 Saverio Minucci,1 Jianming Lu,1 Xiang-Jiao Yang,1 Kristen K. Walker,3 Hongwu Chen,3 Ronald M. Evans,2,3 Yoshihiro Nakatani,1 and Keiko Ozato1,5 1Laboratory of Molecular Growth Regulation, National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, Maryland 20892-2753 USA; 2Howard Hughes Medical Institute; 3The Salk Institute for Biological Studies, La Jolla, California 92037 USA Whereas the histone acetylase PCAF has been suggested to be part of a coactivator complex mediating transcriptional activation by the nuclear hormone receptors, the physical and functional interactions between nuclear receptors and PCAF have remained unclear. Our efforts to clarify these relationships have revealed two novel properties of nuclear receptors. First, we demonstrate that the RXR/RAR heterodimer directly recruits PCAF from mammalian cell extracts in a ligand-dependent manner and that increased expression of PCAF leads to enhanced retinoid-responsive transcription. Second, we demonstrate that, in vitro, PCAF directly associates with the DNA-binding domain of nuclear receptors, independently of p300/CBP binding, therefore defining a novel cofactor interaction surface. Furthermore, our results show that dissociation of corepressors enables ligand-dependent PCAF binding to the receptors. This observation illuminates how a ligand-dependent receptor function can be propagated to regions outside the ligand-binding domain itself. On the basis of these observations, we suggest that PCAF may play a more central role in nuclear receptor function than previously anticipated. -
Mutant Thyroid Hormone Receptor Represses the Expression And
[CANCER RESEARCH 63, 5274–5280, September 1, 2003] Mutant Thyroid Hormone Receptor  Represses the Expression and Transcriptional Activity of Peroxisome Proliferator-activated Receptor ␥ during Thyroid Carcinogenesis Hao Ying, Hideyo Suzuki, Li Zhao, Mark C. Willingham, Paul Meltzer, and Sheue-Yann Cheng1 Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892-4264 [H. Y., H. S., L. Z., S-Y. C.]; National Human Genome Research Institute, NIH, Bethesda, Maryland 20892-4264 [P. M.]; and Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1072 [M. C. W.] ABSTRACT not in 10 papillary carcinomas. This unique genetic rearrangement in follicular carcinoma was further confirmed by subsequent analyses The molecular genetics underlying thyroid carcinogenesis is not clear. using a larger number of samples (8). When fused to PAX8, PPAR␥1 Recent identification of a PAX8-peroxisome proliferator-activated receptor ␥ ␥ not only loses its capability to stimulate thiazolidinedione-induced (PPAR ) fusion gene in human thyroid follicular carcinoma suggests a ␥ tumor suppressor role of PPAR␥ in thyroid carcinogenesis. Mice harbor- transcription but also acts to inhibit PPAR 1 transcriptional activity ␥ ing a knockin mutant thyroid hormone  receptor (TRPV) spontaneously (7). However, how the loss of PPAR 1 transcriptional activity im- develop thyroid follicular carcinoma through pathological progression of pacts the normal functions of thyroid follicular cells is unclear. hyperplasia, capsular invasion, vascular invasion, anaplasia, and eventu- We have recently created a mutant mouse by targeting a mutation ally, distant organ metastasis. This mutant mouse (TRPV/PV mouse) (PV)totheTR gene locus (TRPV mice; Ref. -
Retinoic Acid-Related Orphan Receptor Rorβ, Circadian Rhythm Abnormalities and Tumorigenesis (Review)
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 35: 1493-1500, 2015 Retinoic acid-related orphan receptor RORβ, circadian rhythm abnormalities and tumorigenesis (Review) SHUJIONG FENG1, SONG XU1, ZHENZHEN WEN1 and YONGLIANG ZHU1,2 1Laboratory of Gastroenterology, The Second Affiliated Hospital of Zhejiang University, School of Medicine; 2Cancer Institute and Education Ministry Key Laboratory of Cancer Prevention and Intervention, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China Received August 8, 2014; Accepted March 12, 2015 DOI: 10.3892/ijmm.2015.2155 Abstract. Nuclear receptors are a superfamily of transcription and have important physiological functions in cell develop- factors including the steroid hormone receptors, non-steroid ment and differentiation, circadian rhythm, metabolism and hormone receptors and the orphan nuclear receptor family. immune regulation. NRs consist of three components: the Retinoic acid-related orphan receptor (ROR)β, as a member of steroid hormone receptors, non-steroid hormone receptors the orphan nuclear receptor family, plays an important regula- and the orphan nuclear receptor family. Steroid and non- tory role in the maintenance of a variety of physiological and steroid hormone receptors have specific ligands, including pathological processes. RORβ has been determined to act as steroid hormones, thyroid hormones, retinoic acids and fatty an osteogenic repressor in regulating bone formation, and is acids. Ligands for orphan NRs have not yet been determined. involved in regulating circadian rhythm. The findings of recent Retinoic acid-related orphan receptors (RORs), also known studies concerning the association between tumorigenesis as nuclear receptor subfamily 1 group F members (NR1F), and circadian rhythm have shown that an aberrant circadian are specified by gene sequences, which are homologous to rhythm may promote tumorigenesis and tumor progression. -
Mutation of Thyroid Hormone Receptor-&Beta
Oncogene (2011) 30, 3381–3390 & 2011 Macmillan Publishers Limited All rights reserved 0950-9232/11 www.nature.com/onc ORIGINAL ARTICLE Mutation of thyroid hormone receptor-b in mice predisposes to the development of mammary tumors CJ Guigon1, DW Kim1, MC Willingham2 and S-y Cheng1 1Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA and 2Department of Pathology, Wake Forest University, Winston-Salem, NC, USA Correlative data suggest that thyroid hormone receptor-b Introduction (TRb) mutations could increase the risk of mammary tumor development, but unequivocal evidence is still Thyroid hormone receptors (TRs) belong to the lacking. To explore the role of TRb mutants in vivo in superfamily of nuclear receptors that are ligand- breast tumor development and progression, we took dependent transcription factors. Two TR genes, THRA advantage of a knock-in mouse model harboring a and THRB, located on chromosomes 17 and 3, respec- mutation in the Thrb gene encoding TRb (ThrbPV mouse). tively, encode four thyroid hormone (T3)-binding Although in adult nulliparous females, a single ThrbPV receptors: TRa1, TRb1, TRb2 and TRb3. They bind allele did not contribute to mammary gland abnormalities, T3 that has critical roles in differentiation, growth and the presence of two ThrbPV alleles led to mammary metabolism (Yen, 2001). hyperplasia in B36% ThrbPV/PV mice. The ThrbPV Several findings support the notion that mutations of mutation further markedly augmented the risk of TRs can be associated with cancer. Early evidence mammary hyperplasia in a mouse model with high suggested that mutated TRs could be involved in susceptibility to mammary tumors (Pten þ /À mouse), as carcinogenesis came from the discovery that v-erbA, a demonstrated by the occurrence of mammary hyperplasia highly mutated chicken THRA1 that has lost the ability in B60% of ThrbPV/ þ Pten þ /À and B77% of ThrbPV/PV to activate gene transcription, leads to neoplastic trans- Pten þ /À mice versus B33% of Thrb þ / þ Pten þ /À mice. -
Epigenomic and Transcriptional Regulation of Hepatic Metabolism by REV-ERB and Hdac3
University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2013 Epigenomic and Transcriptional Regulation of Hepatic Metabolism by REV-ERB and Hdac3 Dan Feng University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Genetics Commons, and the Molecular Biology Commons Recommended Citation Feng, Dan, "Epigenomic and Transcriptional Regulation of Hepatic Metabolism by REV-ERB and Hdac3" (2013). Publicly Accessible Penn Dissertations. 633. https://repository.upenn.edu/edissertations/633 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/633 For more information, please contact [email protected]. Epigenomic and Transcriptional Regulation of Hepatic Metabolism by REV-ERB and Hdac3 Abstract Metabolic activities are regulated by the circadian clock, and disruption of the clock exacerbates metabolic diseases including obesity and diabetes. Transcriptomic studies in metabolic organs suggested that the circadian clock drives the circadian expression of important metabolic genes. Here we show that histone deacetylase 3 (HDAC3) is recruited to the mouse liver genome in a circadian manner. Histone acetylation is inversely related to HDAC3 binding, and this rhythm is lost when HDAC3 is absent. Diurnal recruitment of HDAC3 corresponds to the expression pattern of REV-ERBα, an important component of the circadian clock. REV-ERBα colocalizes with HDAC3 near genes regulating lipid metabolism, and deletion of HDAC3 or Rev-erbα in mouse liver causes hepatic steatosis. Thus, genomic recruitment of HDAC3 by REV-ERBα directs a circadian rhythm of histone acetylation and gene expression required for normal hepatic lipid homeostasis. In addition, we reported that the REV-ERBα paralog, REV- ERBβ also displays circadian binding similar to that of REV-ERBα.